We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$17.4B
AUM Growth
+$966M
Cap. Flow
+$109M
Cap. Flow %
0.63%
Top 10 Hldgs %
55.4%
Holding
4,569
New
1,358
Increased
591
Reduced
744
Closed
1,488

Sector Composition

Rank Sector Weight
1 Financials 8.73%
2 Consumer Discretionary 7.06%
3 Technology 6.81%
4 Industrials 3.97%
5 Healthcare 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKLB icon
2651
PUT
Rocket Lab Corp
RKLB
$51.8B
$146K ﹤0.01%
+11,900
New +$164K
ASTSW
2652
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
$146K ﹤0.01%
50,280
+1,929
+4% +$7.56K
LHC.U
2653
DELISTED
Leo Holdings Corp. II Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant
LHC.U
$146K ﹤0.01%
14,733
IEA
2654
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$146K ﹤0.01%
15,966
+4,867
+44% +$51.1K
CYXTW
2655
DELISTED
Cyxtera Technologies, Inc. Warrant
CYXTW
$146K ﹤0.01%
44,150
-5,151
-10% -$12.6K
CEV
2656
Eaton Vance California Municipal Income Trust
CEV
$73.6M
$145K ﹤0.01%
+10,765
New +$147K
KRP icon
2657
Kimbell Royalty Partners
KRP
$1.48B
$145K ﹤0.01%
10,703
-12,801
-54% -$183K
WALD icon
2658
Waldencast
WALD
$178M
$145K ﹤0.01%
+14,699
New +$145K
THCX
2659
DELISTED
AXS Cannabis ETF
THCX
$144K ﹤0.01%
1,686
-20,870
-93% -$2.29M
ATHX
2660
DELISTED
Athersys, Inc. Common Stock
ATHX
$144K ﹤0.01%
+6,386
New +$183K
HAIAU
2661
DELISTED
Healthcare AI Acquisition Corp. Unit
HAIAU
$143K ﹤0.01%
+14,320
New +$143K
VERU icon
2662
Veru
VERU
$37.4M
$142K ﹤0.01%
+2,414
New +$185K
HYZNW
2663
DELISTED
Hyzon Motors Inc. Warrants
HYZNW
$142K ﹤0.01%
74,985
-11,362
-13% -$20.1K
OHAAU
2664
DELISTED
OPY Acquisition Corp. I Units
OHAAU
$142K ﹤0.01%
+14,369
New +$143K
MDAI icon
2665
Spectral AI
MDAI
$55.7M
$141K ﹤0.01%
+14,439
New +$142K
MLTX icon
2666
MoonLake Immunotherapeutics
MLTX
$1.55B
$141K ﹤0.01%
14,258
+7
+0% +$70
ASTLW icon
2667
Algoma Steel Group Warrant
ASTLW
$140K ﹤0.01%
+48,934
New +$141K
BNZI icon
2668
Banzai International
BNZI
$140K ﹤0.01%
+1
New +$97.7K
TWM icon
2669
ProShares UltraShort Russell2000
TWM
$41.3M
$140K ﹤0.01%
+2,171
New +$140K
CTXR icon
2670
Citius Pharmaceuticals
CTXR
$18.7M
$139K ﹤0.01%
+3,635
New +$165K
CYAD
2671
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$139K ﹤0.01%
+38,105
New +$160K
GERN icon
2672
Geron
GERN
$949M
$138K ﹤0.01%
113,681
-86,031
-43% -$123K
DNZ
2673
DELISTED
D and Z Media Acquisition Corp.
DNZ
$138K ﹤0.01%
+14,200
New +$138K
THCA
2674
DELISTED
Tuscan Holdings Corp. II Common Stock
THCA
$138K ﹤0.01%
13,545
-11,429
-46% -$116K
GGAL icon
2675
Galicia Financial Group
GGAL
$7.42B
$137K ﹤0.01%
+14,488
New +$149K

Similar funds

HRT Financial's Q4 2021 Portfolio in Review

As of Q4 2021, HRT Financial held 4,569 positions worth $17.4B, up 5.9% from $16.4B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

HRT Financial's Q4 2021 filing shows 1,358 new, 591 increased, 744 reduced and 1,488 closed positions. Its largest new stake was Tesla: 1,187,973 shares worth $418M. The largest sale was Invesco QQQ Trust, an estimated $583M.

By sector, the portfolio is most concentrated in Financials at 8.7% of assets, up from 6.7% a quarter earlier, followed by Consumer Discretionary and Technology.

  • HRT Financial's largest Q4 2021 buy was Tesla: 1,187,973 shares worth $418M.
  • HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $943M increase.
  • HRT Financial's biggest Q4 2021 reduction was Invesco QQQ Trust, cutting an estimated $583M.
  • HRT Financial fully exited Merck in Q4 2021, selling an estimated $142M.
  • HRT Financial's ten largest holdings make up 55% of its $17.4B portfolio in Q4 2021.
  • HRT Financial opened 1,358 new positions and closed 1,488 in Q4 2021.
  • HRT Financial's portfolio value rose 5.9% quarter-over-quarter to $17.4B.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.